Examples include BAP1 in cervical and lung cancer [28,29], CDK1 in bladder cancer [30], E2F2 in ovarian cancer [31], and RHOA, VEGF, NUMB, among others, in oral cancer [32]. This evidence concerns the gene CDK1 and ovarian carcinoma.